Business · 18/10/2024Updated: 10/17/2026 · 1 min read

FDA Announces Final Guidance for Industry on Core Patient-Reported Outcomes in Cancer Clinical Trials

The FDA has released a final guidance for industry on collecting core patient-reported clinical outcomes in cancer clinical trials, providing recommendations for sponsors on instrument selection and trial design to demonstrate anti-cancer therapy effects on survival, tumor response, or cancer progression.